Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2018 1
2020 5
2021 12
2022 12
2023 8
2024 6
2025 9
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean peanut (21,566 results)?
Prenatal Magnesium Sulfate Exposure Is Not Associated with Different Neurodevelopmental Outcomes by Sex in Extremely Preterm Infants.
DiNucci KF, Rue TC, Brandon OC, Corry KA, Mayock DE, Heagerty PJ, Juul SE, Wood TR. DiNucci KF, et al. Brain Sci. 2025 Nov 27;15(12):1273. doi: 10.3390/brainsci15121273. Brain Sci. 2025. PMID: 41440069 Free PMC article.
We sought to evaluate sex-dependent associations between prenatal MgSO(4) exposure and standardized neurodevelopmental outcomes in a large, multi-center cohort of extremely preterm neonates (24-0/7 to 27-6/7 weeks' gestation) from the Preterm Erythropoietin Neuroprotection Trial …
We sought to evaluate sex-dependent associations between prenatal MgSO(4) exposure and standardized neurodevelopmental outcomes in a large, …
Acute Kidney Injury and Neurodevelopmental Outcomes in Extremely Premature Neonates: A Secondary Analysis of a Randomized Clinical Trial.
Hanna M, Chock VY, Kamath N, Raj A, Swanson JR, Griffin R, Askenazi DJ, Nesargi S. Hanna M, et al. JAMA Netw Open. 2025 Nov 3;8(11):e2543270. doi: 10.1001/jamanetworkopen.2025.43270. JAMA Netw Open. 2025. PMID: 41222934 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: This study is a secondary analysis of the Preterm Erythropoietin Neuroprotection Trial (PENUT), a phase 3 placebo-controlled randomized clinical trial of erythropoietin conducted from December 2013 to September 2016 in 30 neonatal intensi …
DESIGN, SETTING, AND PARTICIPANTS: This study is a secondary analysis of the Preterm Erythropoietin Neuroprotection Trial (PENUT), a …
Time to regain birthweight and in-hospital outcomes among United States-born extremely preterm newborns.
Valentine GC, Brandon OC, Perez KM, Strobel KM, Mayock DE, Law JB, Neches S, German K, Kolnik S, Heagerty PJ, Wood TR, Juul SE. Valentine GC, et al. Pediatr Res. 2026 Feb;99(3):949-957. doi: 10.1038/s41390-025-04563-3. Epub 2025 Nov 10. Pediatr Res. 2026. PMID: 41214292 Clinical Trial.
METHODS: We performed a secondary analysis of the multicenter Preterm Erythropoietin Neuroprotection (PENUT) Trial including extremely preterm (EP) newborns at 24w0d-27w6d gestation at birth evaluating time-to-regain and its subcomponents with in-hospital adverse outcomes. …
METHODS: We performed a secondary analysis of the multicenter Preterm Erythropoietin Neuroprotection (PENUT) Trial including extremel …
Childhood Differences in Healthcare Utilization Between Extremely Preterm Infants and the General Population.
Patel K, Wood TR, Horner D, Puia-Dumitrescu M, German K, Strobel KM, Perez K, Valentine GC, Law JB, Comstock B, Mayock DE, Heagerty PJ, Juul SE, Kolnik SE. Patel K, et al. Children (Basel). 2025 Jul 25;12(8):979. doi: 10.3390/children12080979. Children (Basel). 2025. PMID: 40868431 Free PMC article.
Methods: This study involved a post hoc analysis of infants born 24-0/7 to 27-6/7 weeks' gestation enrolled in the Preterm Erythropoietin Neuroprotection (PENUT) Trial who had at least one follow-up survey representing their course between 24 and 60 months of age. ...Resul …
Methods: This study involved a post hoc analysis of infants born 24-0/7 to 27-6/7 weeks' gestation enrolled in the Preterm Erythropoietin Ne …
Neurodevelopmental outcomes after red cell transfusion exposure in male versus female extremely preterm infants.
German K, Wood TR, Gogcu S, Heagerty PJ, Mayock DE, Comstock BA, Puia-Dumitrescu M, Kolnik S, Mietzsch U, Law J, Perez K, Valentine G, Bammler TK, Juul SE; PENUT Trial Consortium. German K, et al. Pediatr Res. 2025 Dec;98(6):2186-2194. doi: 10.1038/s41390-025-04149-z. Epub 2025 Jun 2. Pediatr Res. 2025. PMID: 40456918 Clinical Trial.
METHODS: In this post-hoc analysis of the Preterm Erythropoietin Neuroprotection (PENUT) Trial, associations between pRBC transfusion volume and cytokines at 0-7 and 7-14 days, MRI injury, and Bayley Scales of Infant Development (BSID-III) scores at 24 months corrected age …
METHODS: In this post-hoc analysis of the Preterm Erythropoietin Neuroprotection (PENUT) Trial, associations between pRBC transfusion …
Cyclohexanone and metabolites exposure in critically Ill neonates and children.
Desiraju S, Zhao E, Kuiper J, Salorio CF, Graham D, Buckley JP, Russell MW, Graham EM, Gottlieb Sen D, Ellis G, Gilmore M, Jantzie L, Juul SE, Simkhada K, Everett AD, Bembea MM. Desiraju S, et al. Pediatr Res. 2025 Dec;98(6):2270-2277. doi: 10.1038/s41390-025-04027-8. Epub 2025 Apr 5. Pediatr Res. 2025. PMID: 40188215 Free PMC article.
Association of patent ductus arteriosus treatment in extremely low gestational age neonates with two year kidney outcomes: a secondary analysis of the preterm erythropoietin neuroprotection trial (PENUT).
Condit PE, Guillet R, Kaluarachchi D, Griffin RL, Menon S, Askenazi DJ, Harer MW. Condit PE, et al. BMC Nephrol. 2025 Mar 19;26(1):138. doi: 10.1186/s12882-025-04065-8. BMC Nephrol. 2025. PMID: 40108500 Free PMC article. Clinical Trial.

METHODS: Secondary analysis of prospectively collected data from the PENUT trial. Kidney dysfunction defined by: eGFR < 90 mL/min/1.73 m(2), systolic or diastolic blood pressures (SBP or DBP) > 90th percentile, or proteinuria measured by albumin to creatinine ratio (

…

METHODS: Secondary analysis of prospectively collected data from the PENUT trial. Kidney dysfunction defined by: eGFR < 90 mL/min/

…
Association of delayed cord clamping with acute kidney injury and two-year kidney outcomes in extremely premature neonates: a secondary analysis of the preterm erythropoietin neuroprotection trial (PENUT).
Zapata HA, Todurkar N, Favel K, Griffin RL, Starr MC, Charlton JR, McAdams RM, Askenazi D, Kulkarni T, Menon S, Mammen C, Harer MW. Zapata HA, et al. J Perinatol. 2025 Jan;45(1):85-93. doi: 10.1038/s41372-024-02143-7. Epub 2024 Oct 11. J Perinatol. 2025. PMID: 39390245 Free PMC article. Clinical Trial.
47 results